News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investing.com4d agobullish
European shares gain on Novo’s results; markets weigh U.S. midtermsThe Wall Street Journal4d agoneutral
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill ContinuesGuruFocus.com5d agoneutral
Earnings To Watch: Novo Nordisk AS (NVO) Q3 2026 -- GF Value Sees 146% UpsideInvesting.com40d agoneutral
Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug dealThe Wall Street Journal44d agoneutral
Novo Nordisk to Pay Up to $1.3 Billion for Nanexa’s Drug Delivery TechnologyThe Wall Street Journal47d agoneutral
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial